Cesca Therapeutics Inc. | Balance Sheet

Fiscal year is July-June. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
6,884.00
14,811.00
3,357.00
5,835.00
3,623.00
2,400
Total Accounts Receivable
4,898.00
4,693.00
5,133.00
3,169.00
3,701.00
1,509
Inventories
4,259.00
5,606.00
4,598.00
3,593.00
3,617.00
4,493
Other Current Assets
232.00
217.00
163.00
246.00
237.00
224
Total Current Assets
16,273.00
25,327.00
13,251.00
12,843.00
11,178.00
8,626
Net Property, Plant & Equipment
2,208.00
2,298.00
2,937.00
2,962.00
2,330.00
2,562
Intangible Assets
-
35,182.00
34,490.00
34,016.00
33,360.00
2,372
Other Assets
48.00
81.00
79.00
78.00
64.00
51
Total Assets
18,529.00
62,888.00
51,204.00
49,899.00
46,932.00
14,611
Accounts Payable
3,106.00
3,590.00
5,079.00
2,648.00
2,207.00
Other Current Liabilities
2,042.00
2,790.00
2,867.00
2,894.00
2,313.00
Total Current Liabilities
5,148.00
6,380.00
7,946.00
5,542.00
4,520.00
Long-Term Debt
-
-
-
2,489.00
3,500.00
Deferred Taxes
-
7,641.00
7,641.00
7,641.00
6,968.00
Other Liabilities
63.00
169.00
268.00
1,954.00
1,107.00
Total Liabilities
5,211.00
14,190.00
16,302.00
17,626.00
16,095.00
Common Equity (Total)
13,318.00
48,698.00
34,902.00
32,273.00
30,837.00
Total Shareholders' Equity
13,318.00
48,698.00
34,902.00
32,273.00
30,837.00
Total Equity
13,318.00
48,698.00
34,902.00
32,273.00
30,837.00
Liabilities & Shareholders' Equity
18,529.00
62,888.00
51,204.00
49,899.00
46,932.00

About Cesca Therapeutics

View Profile
Address
2711 Citrus Road
Rancho Cordova California 95742
United States
Employees -
Website http://www.cescatherapeutics.com
Updated 07/08/2019
Cesca Therapeutics, Inc. engages in the research, development, and commercialization of autologous cell-based therapeutics for use in regenerative medicine. It operates through the Clinical Development Division and Device Division business segments. The Clinical Development Division segment involves in developing autologous stem cell-based therapeutics that address significant unmet medical needs for applications within the vascular, cardiology, and orthopedic markets.